S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis

Biomarkers

Volumn 18, Issue 3, 2013, Pages 216-220

  Wang, Li Chun ^a   Zhang, Hong Ying ^b   Shao, Lin ^a   Chen, Lin ^a   Liu, Ze Han ^a   He, Xu ^a   Gong, Wei Xun ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Heilongjiang Provincial Forestry General Hospital   (China)

Author keywords

Biomarker; Osteoarthritis; S100A12; Serum; Synovial fluid

Indexed keywords

PROTEIN S 100; PROTEIN S 100 A12; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; KELLGREN LAWRENCE GRADING SYSTEM; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SYMPTOMATOLOGY; SYNOVIAL FLUID LEVEL; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; S100 PROTEINS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID;

EID: 84876582395     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.766262     Document Type: Article

References (22)

1. Altman R, Asch E, Bloch D, et al. (1986). Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 29: 1039-49.
2. Baillet A, Trocmé C, Berthier S, et al. (2010). Synovial fluid proteomic fingerprint: S100A8, S100A9 and S100A12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology (Oxford) 49: 671-82.
3. Bellamy N, Buchanan WW, Goldsmith CH, et al. (1988). Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15: 1833-40. (Pubitemid 19037656)
4. Chayanupatkul M, Honsawek S. (2010). Soluble receptor for advanced glycation end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis. Clin Biochem 43: 1133-7.
5. Donato R. (2001). S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33: 637-68. (Pubitemid 32520962)
6. Felson DT, Zhang Y, Hannan MT, et al. (1995). The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum 38: 1500-5.
7. Foell D, Kane D, Bresnihan B, et al. (2003). Expression of the proinflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology (Oxford) 42: 1383-9. (Pubitemid 37407031)
8. Gerss J, Roth J, Holzinger D, et al. (2012). Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study. Ann Rheum Dis 71: 1991-7.
9. Han EC, Cho SB, Ahn KJ, et al. (2011). Expression of pro-inflammatory protein S100A12 (EN-RAGE) in Behçet's disease and its association with disease activity: a pilot study. Ann Dermatol 23: 313-20.
10. Henrotin Y. (2012). Osteoarthritis year 2011 in review: biochemical markers of osteoarthritis: an overview of research and initiatives. Osteoarthritis Cart 20: 215-17.
11. Kellgren JH, Lawrence JS. (1957). Radiological assessment of osteoarthrosis. Ann Rheum Dis 16: 494-502.
12. Kosaki A, Hasegawa T, Kimura T, et al. (2004). Increased plasma S100A12 (EN-RAGE) levels in patients with type 2 diabetes. J Clin Endocrinol Metab 89: 5423-8. (Pubitemid 39518420)
13. Li ZC, Cheng GQ, Hu KZ, et al. (2011). Correlation of synovial fluid HMGB-1 levels with radiographic severity of knee osteoarthritis. Clin Invest Med 34: E298-303.
14. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. (2012). Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64: 1697-707.
15. Meijer B, Gearry RB, Day AS. (2012). The role of S100A12 as a systemic marker of inflammation. Int J Inflam 2012: 1-6, Article ID 907078.
16. Myles A, Viswanath V, Singh YP, Aggarwal A. (2011). Soluble receptor for advanced glycation endproducts is decreased in patients with juvenile idiopathic arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels. J Rheumatol 38: 1994-9.
17. Nakashima M, Sakai T, Hiraiwa H, et al. (2012). Role of S100A12 in the pathogenesis of osteoarthritis. Biochem Biophys Res Commun 422: 508-14.
18. Perera C, McNeil HP, Geczy CL. (2010). S100 Calgranulins in inflammatory arthritis. Immunol Cell Biol 88: 41-9.
19. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. (2005). Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7: R817-24.
20. Rousseau JCh, Garnero P. (2012). Biological markers in osteoarthritis. Bone 51: 265-77.
21. Stürmer T, Brenner H, Koenig W, Günther KP. (2004). Severity and extent of osteoarthritis and low grade systemic inflammation as assessed by high sensitivity C reactive protein. Ann Rheum Dis 63: 200-5.
22. Xu L, Zhu GB, Wang L, et al. (2012). Synovial fluid omentin-1 levels are inversely correlated with radiographic severity of knee osteoarthritis. J Investig Med 60: 583-6.